Minocycline-induced lymphomatoid papulosis [4];Papulose lymphomatoïde atypique à grandes cellules supposée déclenchée par la minocycline

Revue de Medecine Interne

Volumn 25, Issue 5, 2004, Pages 401-404

  Dukic, R ^a   Derragui, A ^a   Geiss, S ^a   Wilhelm, J M ^a   Thannberger, P ^a   Colson, A ^b   Kieffer, P ^a  

^a Centre Hospitalier Saint Morand   (France)

^b Hôpitaux Universitaires de Strasbourg   (France)

Author keywords

Ad nopathies m diastinales; Lymphomatoid papulomatosis; Mediastinal adenopathies; Mimocycline; Papulose lymphomato de

Indexed keywords

ALLOPURINOL; ANTIINFECTIVE AGENT; ATENOLOL; BARBITURIC ACID DERIVATIVE; CAPTOPRIL; CARBAMAZEPINE; CLOMIPRAMINE; CYCLOSPORIN; DAPSONE; DILTIAZEM; FLUOXETINE; ISONIAZID; MEXILETINE; MINOCYCLINE; PHENYLBUTAZONE; PHENYTOIN; RANITIDINE; SALAZOSULFAPYRIDINE; SULFANILAMIDE; THALIDOMIDE;

CRYOGLOBULINEMIA; DISEASE EXACERBATION; DRUG INDUCED DISEASE; HISTOPATHOLOGY; HUMAN; HYPEREOSINOPHILIA; IMMUNOHISTOCHEMISTRY; LETTER; LEUKOCYTE; LIVER FUNCTION; LYMPHADENOPATHY; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; LYMPHOMATOID PAPULOSIS; MEDIASTINUM DISEASE; PUSTULE; SKIN DISEASE;

ACNE VULGARIS; ADULT; ANTI-BACTERIAL AGENTS; HUMANS; LYMPHOMATOID PAPULOSIS; MALE; MINOCYCLINE;

EID: 2142715906     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.revmed.2004.02.010     Document Type: Letter

References (13)

1. Willemze R., Beljaards R.C. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol. 28:1993;973-980
2. Karp D.L., Horn D.H. Lymphomatoid papulosis. J Am Acad Dermatol. 30:1994;79-95
3. Giannoti B., Santucci M. Lymphomatoid papulosis and associated lymphomas. Arch Dermatol. 129:1993;351-355
4. Wood G.S., Crooks C.F., Ulver A.Z. Lymphomatoid papulosis and associated cutaneous lymphoproliferative disorders exhibit a common clonal origin. J Invest Dermatol. 105:1995;51-55
5. Davis T.H., Morton C.C., Miller-Cassman R., Balk S.P., Kadin M.E. Hodgkin's disease, lymphomatoid papulosis and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med. 326:1992;1115-1122
6. Drend B. La papulose lymphomatoïde. Presse Méd. 24:1995;1084-1087
7. Callot V., Roujeau J.C., Babot M., Wechsler J., Chosidow O., Souteyrand P., et al. Drug induced pseudolymphoma and hypersensitivity syndrome. Arch Dermatol. 132:1996;1315-1321
8. Bocquet H., Bagot M., Roujeau J.C. Drug induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin. Cutaneous Med Surg. 15:1996;250-257
9. Riylaarsdam J.U., Scheffer E., Meijer L.M., Willemze R. Cutaneous pseudo-T-cell lymphomas. A clinicopathologic study of 20 patents. Cancer. 69:1992;717-724
10. Grasset L., Guy C., Ollagnier M. Cyclines et acné: attention aux effets indésirables ! Aspects récents de la littérature. Rev Méd Interne. 24:2003;305-316
11. Piette A.M., Ramanoelina J., Gepner P., Larroche C., Bletry O. Réactions systémiques secondaires à la prise de minocycline. À propos de quatre observations et revue de la littérature. Rev Méd Interne. 20:1999;869-874
12. Gottlieb A. Safety of minocycline for acne. Lancet. 1997;349-374
13. Masson C., Yakova M. Minocycline: Hyde ou Jekyl? Rev Méd Interne. 20:1999;859-862